Pardossi, S.;                     Cuomo, A.;                     Gualtieri, G.;                     Pinzi, M.;                     Piumini, G.;                     Fagiolini, A.    
        Valproate-Enhanced Protocols for Alcohol Withdrawal Syndrome: A Brief Review and Retrospective Study of Efficacy and the Ability to Reduce Benzodiazepine Use. Pharmaceuticals 2025, 18, 855.
    https://doi.org/10.3390/ph18060855
    AMA Style
    
                                Pardossi S,                                 Cuomo A,                                 Gualtieri G,                                 Pinzi M,                                 Piumini G,                                 Fagiolini A.        
                Valproate-Enhanced Protocols for Alcohol Withdrawal Syndrome: A Brief Review and Retrospective Study of Efficacy and the Ability to Reduce Benzodiazepine Use. Pharmaceuticals. 2025; 18(6):855.
        https://doi.org/10.3390/ph18060855
    
    Chicago/Turabian Style
    
                                Pardossi, Simone,                                 Alessandro Cuomo,                                 Giacomo Gualtieri,                                 Mario Pinzi,                                 Giuditta Piumini,                                 and Andrea Fagiolini.        
                2025. "Valproate-Enhanced Protocols for Alcohol Withdrawal Syndrome: A Brief Review and Retrospective Study of Efficacy and the Ability to Reduce Benzodiazepine Use" Pharmaceuticals 18, no. 6: 855.
        https://doi.org/10.3390/ph18060855
    
    APA Style
    
                                Pardossi, S.,                                 Cuomo, A.,                                 Gualtieri, G.,                                 Pinzi, M.,                                 Piumini, G.,                                 & Fagiolini, A.        
        
        (2025). Valproate-Enhanced Protocols for Alcohol Withdrawal Syndrome: A Brief Review and Retrospective Study of Efficacy and the Ability to Reduce Benzodiazepine Use. Pharmaceuticals, 18(6), 855.
        https://doi.org/10.3390/ph18060855